Inicio>>Signaling Pathways>> PROTAC>>PROTAC ERα Degrader-1

PROTAC ERα Degrader-1

Catalog No.GC34341

PROTAC ER&alfa; Degrader-1 comprende un grupo de unión a ubiquitina E3 ligasa, un enlazador y un grupo de unión a proteína. PROTAC ER&alfa; Extractos de degradador-1 de la patente WO2017201449A1, compuesto P1. PROTAC ER&alfa; El degradador-1 es un degradador del receptor de estrógeno alfa (ERα).

Products are for research use only. Not for human use. We do not sell to patients.

PROTAC ERα Degrader-1 Chemical Structure

Cas No.: 2417369-94-7

Tamaño Precio Disponibilidad Cantidad
5mg
1.011,00 $
Disponible
10mg
1.563,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

PROTAC ERα Degrader-1 comprises an ubiquitin E3 ligase binding group, a linker and a protein binding group. PROTAC ERα Degrader-1 extracts from patent WO2017201449A1, compound P1. PROTAC ERα Degrader-1 is an estrogen receptor-alpha (ERα) degrader.

Treatment of the HER2 expressing cells with the PROTAC ERα Degrader-1 (without Ab; compound P1) results in a decreased estrogen receptor-alpha (ERα) levels[1].

[1]. Thomas Pillow, et al. Protac antibody conjugates and methods of use. WO2017201449A1.

Reseñas

Review for PROTAC ERα Degrader-1

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PROTAC ERα Degrader-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.